SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Valiant Laboratories - Quaterly Results

08 Aug 2025 Evaluate
The Total revenue for the quarter ended June 2025 of  Rs. 510.07 millions grew by 170.11% from Rs. 188.84 millions.The Total Profit for the quarter ended June 2025 of Rs. 18.17 millions grew from Rs.-10.05 millions Operating profit Margin for the quarter ended June 2025 improved to 30.34% as compared to -2.14% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 510.07 188.84 170.11 510.07 188.84 170.11 1333.62 1820.52 -26.75
Other Income 6.71 21.74 -69.14 6.71 21.74 -69.14 54.28 96.82 -43.94
PBIDT 30.34 -2.14 -1517.76 30.34 -2.14 -1517.76 7.53 12.73 -40.85
Interest 0.73 0.53 37.74 0.73 0.53 37.74 1.75 0.78 124.36
PBDT 29.61 -2.67 -1208.99 29.61 -2.67 -1208.99 5.78 11.95 -51.63
Depreciation 5.14 5.04 1.98 5.14 5.04 1.98 20.25 19.48 3.95
PBT 24.47 -7.71 -417.38 24.47 -7.71 -417.38 -14.47 -7.53 92.16
TAX 6.30 2.34 169.23 6.30 2.34 169.23 7.02 -10.93 -164.23
Deferred Tax 0.46 1.46 -68.49 0.46 1.46 -68.49 6.46 -1.11 -681.98
PAT 18.17 -10.05 -280.80 18.17 -10.05 -280.80 -21.49 3.40 -732.06
Equity 434.50 434.50 0.00 434.50 434.50 0.00 434.50 434.50 0.00
PBIDTM(%) 5.95 -1.13 -624.90 5.95 -1.13 -624.90 0.56 0.70 -19.26

Valiant Laboratories Share Price

67.00 0.30 (0.45%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×